S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

NCT00107380 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

86

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: prednisone
DRUG: vincristine sulfate
RADIATION: tositumomab and iodine I 131 tositumomab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]